Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
Date:11/7/2007

. The Company ended the quarter with $38.3 million in cash and cash equivalents, securities available-for-sale, and interest receivable before taking into account $4.5 million in VAT receivables.

About ZEVALIN(R)

ZEVALIN(R) is a form of cancer therapy called radioimmunotherapy and is indicated for the treatment of patients with relapsed or refractory low-grade or follicular B-cell NHL, including patients with Rituximab-refractory NHL. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab infusions. Yttrium-90 ZEVALIN administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the ZEVALIN therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to ZEVALIN therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). ZEVALIN should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit http://www.zevalin.com for more information.

About Pixantrone

Pixantrone is an investigational agent under development for the potential treatment of various hematological malignancies, solid tumors and immunological disorders. It was developed to improve the activity and safety of the anthracycline family of anti-cancer agents. Anthracyclines have been shown to be very active clinically in a number of tumor types. However, they are usua
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
2. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
3. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. Haemacure Reports Third Quarter 2007 Results
8. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. MDS Reports Third Quarter 2007 Results
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Concorde Career Colleges, Inc., announced today the appointment ... manage day-to-day operations for the privately held career college ... to help our Concorde team deliver on our commitment ... part due to reports like Beyond College Rankings from ... and Portland.” , Bell brings 14 years of executive ...
(Date:6/2/2015)... On March 19th, 2015, LiveToBeSober.org held ... Hall of Legends at Detroit’s Ford Field. Hosted by ... Moore, the goal of the conference was to raise ... highlight the benefits of effective professional rehabilitation programs. It ... options that are available to them in regards to ...
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 The ... encouraged viewers to watch the station’s 6:00 a.m. Good Morning ... be entered on the station’s Facebook page. , ... other code-entering participants. She plans to apply the monthly ... months. Allen, a stay-at-home mom, expressed her surprise and ...
(Date:6/2/2015)... June 02, 2015 Bitscape Infotech today ... 2015 Microsoft Worldwide Small and Midsized Cloud Solutions Award. ... top Microsoft partners for demonstrating excellence in innovation and ... , “This comes as no surprise to us as ... year consecutively at worldwide level by Microsoft. We will ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Milton Hershey ... one of the 30 members of the Physician Assistant ... of Medicine. He was presented with a white coat, ... , “We are extremely proud of Vincent’s accomplishments both ... “He is a great example of how a top-notch ...
Breaking Medicine News(10 mins):Health News:Concorde Career Colleges Announces New President and COO 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3
... BullMarket.com ( http://www.bullmarket.com ), an online investment newsletter ... subscribers with updated coverage of several biotech stocks, including ... GILD ), Celgene (Nasdaq: CELG ... Pharmaceuticals (Nasdaq: VRTX ).All paid and trial ...
... congressman to lead debate on improving patient careWASHINGTON, March ... today announced that Tony Coelho will serve as chairperson ... congressman and primary author of the Americans with Disabilities ... people with disabilities for 40 years."I,m excited about the ...
... national health workforce planningWASHINGTON, March 12 Health system reform cannot be ... policy, Dr. Steven A. Wartman, president and CEO of the Association of ... hearing on W orkforc e ... Hea lth Care Re ...
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and ... the White House health reform summit in Dearborn, Michigan ... offer solutions to the healthcare crisis we are now ... White House health reform summits taking place in Dearborn ...
... in cancer and nutrition are meeting in Zurich, Switzerland ... of the most important and fiercely debated topics in ... , There is growing evidence that many cancers may ... diet. In addition, nutritional problems can also have a ...
... a.m. EST, March 12, 2009) People over 80 years ... do not appear to benefit from most commonly prescribed heart ... Institute and published in the March 15 issue of The ... continues to live longer lives, often surviving with heart failure ...
Cached Medicine News:Health News:BullMarket.com Updates Outlook on Biotech Stocks 2Health News:Tony Coelho is Named New Chair of Coalition for Comparative Effectiveness Research 2Health News:Health Reform Must Include Health Workforce, AAHC President Tells Congress 2Health News:White House Healthcare Summit Offers Opportunity for Input Into Reform 2Health News:White House Healthcare Summit Offers Opportunity for Input Into Reform 3Health News:New data on link between cancer and nutrition discussed at European symposium 2Health News:Older patients with 1 type of heart failure may receive little or no benefit from drugs 2
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... of the "Europe Fluoroscopy Market - Growth, Trends ... offering. The European market for Fluoroscopy is ... to 2020 Fluoroscopy is used to view ... catheter through blood vessels, bile ducts or the urinary ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ... the "Laboratory Centrifuges - Global Strategic Business ... Annual estimates and forecasts are provided for the ... analysis is provided for these markets. Market data ... research. Company profiles are primarily based on public ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/sn8mlw/picture_archiving ) has announced the ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... the period 2014 through 2020. Also, a seven-year historic analysis ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... 2012 Lilly Diabetes today announced a donation of ... The contribution will support the Foundation,s mission to empower ... lives to the fullest. The Foundation will use the ... 1 diabetes as well as conference scholarships for families ...
... April 3, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... District Court for the District of Delaware has ruled ... 7,410,978 (the ,978 Patent), 7,759,359 (the ,359 Patent), 7,781,448 ... (the ,635 Patent) for Sanctura XR® (trospium chloride extended-release ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... involved in the control of the growth ... which synthesize and secrete male and female ... FSH is controlled by these sex hormones ... FSH Quantitative Test Kit is based on ...
... Our Class II Direct to High Res SSP kits ... a single tray. Locus specific typing on a single ... , Straight from genomic DNA to high resolution ... Allele level typing with a single tray , Unique ...
... to High Res SSP kits provide high resolution typing ... specific typing on a single tray reduces QC and ... genomic DNA to high resolution results, no need for ... a single tray , Unique reaction pattern for most ...
Medicine Products: